HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic apheresis exchange in two patients with prolidase deficiency.

AbstractBACKGROUND:
Prolidase deficiency is a rare genetic disorder for which a cure has not yet been found.
OBJECTIVES:
To assess the effectiveness of apheresis exchange as a new therapeutic approach.
METHODS:
Apheresis exchanges were repeated monthly for four consecutive months, in parallel, on two patients, replacing prolidase-deficient red blood cells with normal filtered cells. Prolidase activity and urinary dipeptides were determined at regular intervals.
RESULTS:
The constant presence of active prolidase inside cells allowed a continuous, although partial, degradation of imidodipeptides, with a concomitant improvement of skin ulceration.
CONCLUSIONS:
Apheresis exchange could be a reasonable way of obtaining a clinical improvement in these patients.
AuthorsA Lupi, B Casado, M Soli, M Bertazzoni, L Annovazzi, S Viglio, G Cetta, P Iadarola
JournalThe British journal of dermatology (Br J Dermatol) Vol. 147 Issue 6 Pg. 1237-40 (Dec 2002) ISSN: 0007-0963 [Print] England
PMID12452876 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dipeptidases
  • proline dipeptidase
Topics
  • Adult
  • Blood Component Removal (methods)
  • Dipeptidases (deficiency)
  • Electrophoresis, Capillary
  • Erythrocytes (enzymology)
  • Female
  • Follow-Up Studies
  • Humans
  • Leg Ulcer (therapy)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: